Tech Company Financing Transactions
ACEA Biosciences Funding Round
Lilly Asia Ventures and Qiming Ventures participated in a $30 million venture round for ACEA Biosciences. The round was announced on 11/10/2015.
Transaction Overview
Company Name
Announced On
11/10/2015
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
Lilly Asia Ventures (Yi Shi)
Qiming Ventures (Nisa Leung)
Proceeds Purpose
The new round financing provided by two premiere venture capital funds validates the rapid progress of our clinical pipeline, as well as our leading edge approach to drug discovery,' stated Dr. Xiao Xu, President and CEO of ACEA.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6779 Mesa Ridge Rd. 100
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
ACEA Biosciences offers high performance Flow Cytometers and Label Free Real Time Analyzers for Cell Based Assays. Learn more here!
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James O'Connell
Chief Technical Officer
Xiaobo Wang
Co-Founder
Lin Jixun
Co-Founder
Feng Lin
Browse more venture capital transactions:
Prev: 11/10/2015: Tenable Holdings venture capital transaction
Next: 11/10/2015: POPin venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs